Medicine Grand Rounds-Dr. Raj Kasthuri presents: “Hereditary Hemorrhagic Telangiectasia: State of the Art in 2023.”

Raj Kasthuri is a Professor in the Division of Hematology at the University of North Carolina at Chapel Hill. Dr. Kasthuri completed his residency training in Internal Medicine at the Michael Reese Hospital and Medical Center in Chicago before pursuing a fellowship in Hematology and Medical Oncology at the University of Minnesota. He joined the faculty at UNC Chapel Hill in 2007.

Dr. Kasthuri’s clinical and research interests are in disorders of Hemostasis and Thrombosis, and Hereditary Hemorrhagic Telangiectasia (HHT). He is the Director of the UNC HHT Center of Excellence and the Associate Director for Clinical Research at the UNC Blood Research Center. He was involved in the design and conduct of a number of clinical trials in HHT, two of which are ongoing.

The UNC HHT Center is one of a few centers in the country that were awarded federal funding by the Health Resources and Services Administration (HRSA) in 2022. Dr. Kasthuri has collaborated with the Cure HHT foundation on a number of physician and patient education efforts over the last 12 years.